Rockwell Medical Presents New Data on Proprietary Iron-Delivery Drug SFP at ... - Stock Markets Review |
|
|
Stock Markets ReviewSFP is a novel, investigational, continuous iron therapy in late-stage clinical development, designed to treat iron deficiency anemia in ESRD patients.
|